当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 资产负债表

海尔生物

(688139)

  

流通市值:111.92亿  总市值:111.92亿
流通股本:3.18亿   总股本:3.18亿

资产负债表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
流动资产:
  货币资金691,844,623.72654,325,470.06831,055,160.95901,227,075.69
  交易性金融资产653,414,470.32792,041,914.78894,915,823877,249,950.54
  应收票据及应收账款439,846,071.91423,793,436.72444,649,434.93330,991,696.12
  其中:应收票据8,857,425.9619,032,258.5712,751,992.997,145,875.33
        应收账款430,988,645.95404,761,178.15431,897,441.94323,845,820.79
  应收款项融资13,366,860.0512,193,257.6314,862,320.1512,418,141.22
  预付款项33,162,032.341,668,946.2620,042,685.0627,267,096.16
  其他应收款合计7,688,434.947,719,453.497,810,091.818,556,956.91
  存货316,654,053.99303,027,739.69303,739,515.42334,744,974.95
  合同资产8,107,246.268,101,904.359,200,569.819,348,923.99
  一年内到期的非流动资产373,680,826.88353,317,848.03327,082,511.02126,539,483.63
  其他流动资产12,313,030.6110,904,508.9710,062,997.8124,103,642.14
  流动资产合计2,550,077,650.982,607,094,479.982,863,421,109.962,652,447,941.35
非流动资产:
  长期股权投资187,238,645.78185,774,018.6183,880,063.55137,987,031.94
  其他权益工具投资40,206,222.5440,206,222.5441,397,596.4741,397,596.47
  其他非流动金融资产18,000,00018,000,0009,000,0009,000,000
  投资性房地产8,281,179.728,473,340.978,660,741.258,857,663.47
  固定资产862,519,384.29781,279,972.13791,880,590.41807,291,286.02
  在建工程57,539,589.63115,345,386.15101,101,731.595,034,029.25
  使用权资产10,064,262.4610,554,612.4611,548,025.6712,854,331.79
  无形资产369,914,583.78382,234,442.22392,870,662.41402,302,641.03
  商誉758,387,976.51758,734,827.93758,097,771.67757,866,205.38
  长期待摊费用6,149,601.535,901,732.976,331,467.56,715,706
  递延所得税资产83,165,709.9776,207,932.8166,673,482.5566,008,575.05
  其他非流动资产698,899,615.25622,272,642.98595,577,358.5789,705,787.26
  非流动资产合计3,100,366,771.463,004,985,131.762,967,019,491.483,135,020,853.66
  资产总计5,650,444,422.445,612,079,611.745,830,440,601.445,787,468,795.01
流动负债:
  短期借款10,006,50010,005,055.5610,007,777.7810,009,027.78
  应付票据及应付账款415,356,450.33405,738,043.59466,777,643.97427,598,354.67
  其中:应付票据105,592,011.84120,188,305.31105,880,065.9190,192,201.48
        应付账款309,764,438.49285,549,738.28360,897,578.06337,406,153.19
  合同负债92,609,220.5588,353,110.0985,129,205.55151,984,833.74
  应付职工薪酬75,423,297.7470,694,265.5766,785,937.3983,940,305.47
  应交税费48,592,059.6947,808,653.7951,878,400.3750,913,525.45
  其他应付款合计255,233,126.45255,084,363.87262,472,171.51273,354,626.83
  一年内到期的非流动负债21,799,306.4212,032,864.5913,126,023.0313,204,768.63
  其他流动负债7,272,677.147,560,086.3810,729,877.3711,398,099.94
  流动负债合计926,292,638.32897,276,443.44966,907,036.971,022,403,542.51
非流动负债:
  长期借款-10,006,50010,007,222.22-
  租赁负债6,737,003.086,092,033.397,018,616.987,432,212.61
  长期应付款57,283,117.6456,606,273.4855,929,429.3255,252,585.16
  预计负债6,497,810.7812,969,721.338,560,784.758,560,784.75
  递延收益20,721,062.0721,536,973.2322,352,884.6223,168,795.89
  递延所得税负债47,536,844.0249,221,135.150,863,349.8352,514,841.3
  非流动负债合计138,775,837.59156,432,636.53154,732,287.72146,929,219.71
  负债合计1,065,068,475.911,053,709,079.971,121,639,324.691,169,332,762.22
所有者权益(或股东权益):
  实收资本(或股本)317,952,508317,952,508317,952,508317,952,508
  资本公积1,981,720,560.131,980,027,786.851,978,331,416.731,977,335,357.14
  减:库存股231,888,823.98202,512,658.31167,204,433.14140,197,717.52
  其他综合收益-2,395,903.04-2,068,108.49-2,236,031.38-2,693,310.15
  盈余公积158,976,254158,976,254158,976,254158,976,254
  未分配利润2,111,258,117.992,055,606,402.432,170,435,659.892,060,177,419.54
  归属于母公司股东权益合计4,335,622,713.14,307,982,184.484,456,255,374.14,371,550,511.01
  少数股东权益249,753,233.43250,388,347.29252,545,902.65246,585,521.78
  股东权益合计4,585,375,946.534,558,370,531.774,708,801,276.754,618,136,032.79
  负债和股东权益合计5,650,444,422.445,612,079,611.745,830,440,601.445,787,468,795.01
公告日期2025-10-312025-08-272025-04-302025-03-29
审计意见(境内)标准无保留意见
TOP↑